EQS-CMS: Nemetschek SE: Release of a capital market information
EQS Post-admission Duties announcement: Nemetschek SE / Transaction in own shares Nemetschek SE: Release of a capital market information 05.02.2025 / 15:50 CET/CEST Dissemination of a ...
Aya Gold & Silver Expands Boumadine Footprint, Adding 4 Mining Licences and a 600 km² Exploration Authorization
Aya Gold & Silver Inc. is a rapidly growing, Canada-based silver producer with operations in the Kingdom of Morocco.
Board Approves $4 billion Share Repurchase Authorization and Quarterly Dividend
Ball Corporation's (NYSE: BALL) board of directors (the "Board") today declared a cash dividend of 20 cents per share, ...
Nasdaq9d
Board Approves $4 billion Share Repurchase Authorization and Quarterly Dividend
WESTMINSTER, Colo., Jan. 29, 2025 /PRNewswire/ -- Ball Corporation's (NYSE: BALL) board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable March 17, 2025 ...
Aya Gold & Silver Inc.: Aya Gold & Silver Expands Boumadine Footprint, Adding 4 Mining Licences and a 600 km² Exploration Authorization
Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) ("Aya" or the "Corporation") is pleased to announce it has secured the right to four (4) additional mining ...
TMCnet2d
RenaissanceRe Holdings Ltd. Announces Thirtieth Consecutive Annual Increase in Quarterly Dividend and Renewal of Share Repurchase Program
The Board of Directors of RenaissanceRe Holdings Ltd. (NYSE: RNR) today voted to increase the Company's quarterly dividend to $0.40 per common share, from $0.39 per common share.
Merck's CAPVAXIVE gains CHMP nod for EU authorization
RAHWAY, N.J. - Merck & Co ., Inc. (NYSE:MRK) has received a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for its pneumococcal ...
Food23d
FDA removes Red No. 3 authorization, tees up mandatory reformulations
The FDA continues its regulation pronouncement streak, changing its authorization of Red No ... Lurie added in a news release. FDA makes changes ahead of second Trump Administration In the ...
Business Wire25d
Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization ... Inc. This press release contains forward-looking ...
Nasdaq15d
DNOW Announces a New $160 Million Share Repurchase Program Authorization
Information regarding share repurchases will be available in the Company’s periodic reports on Form 10-Q and 10-K filed ... Statements made in this press release that are forward-looking in ...